This may act to counter the proliferative effects of MYC, cyclin D1 and MDM2; however, and concerningly, CDKN1A is also overexpressed in clear-cell renal cell carcinoma relative to normal kidney. The gene discussed is CCND1; the disease is clear cell renal carcinoma.